Genomic characterization of patients (pts) with de-novo high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) compared to those without dn-hv-mCSPC.-MedSci.cn

Genomic characterization of patients (pts) with de-novo high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) compared to those without dn-hv-mCSPC.

Sayegh, N; Jo, Y; Tripathi, N; McFarland, TR; Kessel, A; Nussenzveig, R; Chigarira, B; Li, H; Tandar, C; Sahu, KK; Haaland, B; Maughan, BL; Swami, U; Agarwal, N

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (6):

科室
- - 订阅+
  - 更多科室
工具
服务